b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="rr" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2253533/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Effects of intranasal TNF\xce\xb1 on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2253533/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Respiratory Research" /><meta name="citation_title" content="Effects of intranasal TNF\xce\xb1 on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis" /><meta name="citation_authors" content="Henrik Widegren, Jonas Erjef\xc3\xa4lt, Magnus Korsgren, Morgan Andersson, Lennart Greiff" /><meta name="citation_date" content="2008" /><meta name="citation_issue" content="1" /><meta name="citation_volume" content="9" /><meta name="citation_firstpage" content="15" /><meta name="citation_doi" content="10.1186/1465-9921-9-15" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2253533/?report=abstract" /><meta name="citation_pmid" content="18234086" /><meta name="DC.Title" content="Effects of intranasal TNF\xce\xb1 on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BioMed Central" /><meta name="DC.Contributor" content="Henrik Widegren" /><meta name="DC.Contributor" content="Jonas Erjef\xc3\xa4lt" /><meta name="DC.Contributor" content="Magnus Korsgren" /><meta name="DC.Contributor" content="Morgan Andersson" /><meta name="DC.Contributor" content="Lennart Greiff" /><meta name="DC.Date" content="2008" /><meta name="DC.Identifier" content="10.1186/1465-9921-9-15" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Effects of intranasal TNF\xce\xb1 on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis" /><meta property="og:type" content="article" /><meta property="og:description" content="TNF\xce\xb1 may contribute to the pathophysiology of airway inflammation. For example, we have recently shown that nasal administration of TNF\xce\xb1 produces late phase co-appearance of granulocyte and plasma exudation markers on the mucosal surface. ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2253533/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-rr.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2253533/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2253533/pdf/1465-9921-9-15.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BE427E99A08310000000009CD09CA.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/80/">Respir Res</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/161284/">v.9(1); 2008</a></li><li class="accid">PMC2253533</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-rr.png" alt="Logo of rr" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher\'s site" title="Link to Publisher\'s site" shape="default" coords="0,0,499,74" href="https://respiratory-research.biomedcentral.com/" target="pmc_ext" ref="reftype=publisher&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Respir Res</span>. 2008; 9(1): 15. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Jan 30. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1465-9921-9-15" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1465-9921-9-15</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2253533</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18234086">18234086</a></div></div></div></div><h1 class="content-title">Effects of intranasal TNF&#x003b1; on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Widegren%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18234086" id="A1" class="affpopup" co-rid="_co_idm140446785504512" co-class="co-affbox">Henrik Widegren</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup> <a href="/pubmed/?term=Erjef%26%23x000e4%3Blt%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18234086" id="A2" class="affpopup" co-rid="_co_idm140446750481760" co-class="co-affbox">Jonas Erjef&#x000e4;lt</a>,<sup>2</sup> <a href="/pubmed/?term=Korsgren%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18234086" id="A3" class="affpopup" co-rid="_co_idm140446750478800" co-class="co-affbox">Magnus Korsgren</a>,<sup>3</sup> <a href="/pubmed/?term=Andersson%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18234086" id="A4" class="affpopup" co-rid="_co_idm140446750475840" co-class="co-affbox">Morgan Andersson</a>,<sup>1</sup> and  <a href="/pubmed/?term=Greiff%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18234086" id="A5" class="affpopup" co-rid="_co_idm140446750472880" co-class="co-affbox">Lennart Greiff</a><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140446785504512"><h3 class="no_margin">Henrik Widegren</h3><p><sup>1</sup>Department of Otorhinolaryngology, Head &#x00026; Neck Surgery, Lund University Hospital, Lund, Sweden</p><div>Find articles by <a href="/pubmed/?term=Widegren%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18234086">Henrik Widegren</a></div></div><div id="_co_idm140446750481760"><h3 class="no_margin">Jonas Erjef&#x000e4;lt</h3><p><sup>2</sup>Department of Experimental Medical Sciences, Lund University, Lund, Sweden</p><div>Find articles by <a href="/pubmed/?term=Erjef%26%23x000e4%3Blt%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18234086">Jonas Erjef&#x000e4;lt</a></div></div><div id="_co_idm140446750478800"><h3 class="no_margin">Magnus Korsgren</h3><p><sup>3</sup>Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden</p><div>Find articles by <a href="/pubmed/?term=Korsgren%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18234086">Magnus Korsgren</a></div></div><div id="_co_idm140446750475840"><h3 class="no_margin">Morgan Andersson</h3><p><sup>1</sup>Department of Otorhinolaryngology, Head &#x00026; Neck Surgery, Lund University Hospital, Lund, Sweden</p><div>Find articles by <a href="/pubmed/?term=Andersson%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18234086">Morgan Andersson</a></div></div><div id="_co_idm140446750472880"><h3 class="no_margin">Lennart Greiff</h3><p><sup>1</sup>Department of Otorhinolaryngology, Head &#x00026; Neck Surgery, Lund University Hospital, Lund, Sweden</p><div>Find articles by <a href="/pubmed/?term=Greiff%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18234086">Lennart Greiff</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140446749722672_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140446749722672_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140446749722672_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140446749722672_ai" style="display:none"><div class="fm-affl" lang="en" id="I1"><sup>1</sup>Department of Otorhinolaryngology, Head &#x00026; Neck Surgery, Lund University Hospital, Lund, Sweden</div><div class="fm-affl" lang="en" id="I2"><sup>2</sup>Department of Experimental Medical Sciences, Lund University, Lund, Sweden</div><div class="fm-affl" lang="en" id="I3"><sup>3</sup>Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><span class="contrib-email" id="A1">Henrik Widegren: <a href="mailto:dev@null" data-email="es.enaks@nergediw.kirneh" class="oemail">es.enaks@nergediw.kirneh</a>; </span> <span class="contrib-email" id="A2">Jonas Erjef&#x000e4;lt: <a href="mailto:dev@null" data-email="es.ul.dem@tlafejre.sanoj" class="oemail">es.ul.dem@tlafejre.sanoj</a>; </span> <span class="contrib-email" id="A3">Magnus Korsgren: <a href="mailto:dev@null" data-email="moc.acenezartsa@nergsrok.sungam" class="oemail">moc.acenezartsa@nergsrok.sungam</a>; </span> <span class="contrib-email" id="A4">Morgan Andersson: <a href="mailto:dev@null" data-email="es.enaks@nossredna.nagrom" class="oemail">es.enaks@nossredna.nagrom</a>; </span> <span class="contrib-email" id="A5">Lennart Greiff: <a href="mailto:dev@null" data-email="es.enaks@ffierg.trannel" class="oemail">es.enaks@ffierg.trannel</a></span> </div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140446749722672_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2007 Nov 6; Accepted 2008 Jan 30.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140446749722672_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2008 Widegren et al; licensee BioMed Central Ltd.</div><div class="license half_rhythm"><p id="__p1">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/2.0" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/2.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2253533/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140446750259776" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140446750259776title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p2" class="p p-first-last">TNF&#x003b1; may contribute to the pathophysiology of airway inflammation. For example, we have recently shown that nasal administration of TNF&#x003b1; produces late phase co-appearance of granulocyte and plasma exudation markers on the mucosal surface. The objective of the present study was to examine indices of granulocyte presence and activity in response to intranasal TNF&#x003b1; challenge.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p3" class="p p-first-last">Healthy subjects and patients with allergic rhinitis (examined out of season) were subjected to nasal challenge with TNF&#x003b1; (10 &#x003bc;g) in a sham-controlled and crossover design. Nasal lavages were carried out prior to and 24 hours post challenge. Nasal biopsies were obtained post challenge. Nasal lavage fluid levels of myeloperoxidase (MPO) and eosinophil cationic protein (ECP) were analyzed as indices of neutrophil and eosinophil activity. Moreover, IL-8 and &#x003b1;<sub>2</sub>-macroglobulin were analyzed as markers of pro-inflammatory cytokine production and plasma exudation. Nasal biopsy numbers of neutrophils and eosinophils were monitored.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p4" class="p p-first-last">Nasal lavage fluid levels of MPO recorded 24 hours post TNF&#x003b1; challenge were increased in healthy subjects (p = 0.0081) and in patients with allergic rhinitis (p = 0.0081) (<em>c.f</em>. sham challenge). Similarly, &#x003b1;<sub>2</sub>-macroglobulin was increased in healthy subjects (p = 0.014) and in patients with allergic rhinitis (p = 0.0034). Lavage fluid levels of ECP and IL-8 were not affected by TNF&#x003b1; challenge. TNF&#x003b1; increased the numbers of subepithelial neutrophils (p = 0.0021), but not the numbers of eosinophils.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p5" class="p p-first-last">TNF&#x003b1; produces a nasal inflammatory response in humans that is characterised by late phase (i.e., 24 hours post challenge) neutrophil activity and plasma exudation.</p></div></div></div><div id="__sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec5title">Background</h2><p id="__p6" class="p p-first">Tumour necrosis factor-&#x003b1; (TNF&#x003b1;) is an important pro-inflammatory cytokine of the immune system. Dysregulated TNF&#x003b1; responses are implicated in several inflammatory diseases including rheumatoid arthritis. In this condition, TNF&#x003b1; antagonism, either with recombinant soluble receptors or neutralising antibodies, improves disease activity scores [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400940">1</a>].</p><p id="__p7">In human bronchial airways, TNF&#x003b1; is produced by several cell types including macrophages [<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400955">2</a>], eosinophils [<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400923">3</a>,<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400951">4</a>], epithelial cells [<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400960">5</a>,<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400933">6</a>], and mast cells [<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400935">7</a>,<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400930">8</a>]. Inhalation of TNF&#x003b1; produces a response that is characterized by increased sputum numbers of granulocytes and increased airway responsiveness [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400956">9</a>,<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400925">10</a>]. Furthermore, in refractory asthma, treatment with etanercept, an anti-TNF&#x003b1; measure, is associated with improvement in asthma symptoms, lung function, and airway hyperresponsiveness [<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400950">11</a>,<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400945">12</a>]. While these observations suggest an association between TNF&#x003b1; and bronchial airway inflammation, little is known about TNF&#x003b1;-induced nasal airway responses in man.</p><p id="__p8">Focusing on human nasal airways, patients suffering from allergic rhinitis have been shown to feature increased tissue expression of TNF&#x003b1; mRNA and increased nasal mucosal output of TNF&#x003b1; [<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400928">13</a>-<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400947">15</a>]. Furthermore, in a preliminary study, we have shown that while nasal challenge with TNF&#x003b1; fails to produce acute effects, it produces late-phase plasma exudation (i.e., extravasation and luminal entry of plasma) [<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400929">16</a>], a response characteristic of on-going inflammation [<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400924">17</a>]. We have also observed that this response may be associated with increased nasal mucosal output of granulocyte mediators [<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400932">16</a>]. While our observations suggest a role for TNF&#x003b1; in upper airway conditions characterised by inflammation, information on the nature of this response is scarce. Further information in this field is warranted for several reasons: it may be used to determine whether or not anti-TNF measures should be evaluated for upper respiratory tract conditions. Furthermore, studies in allergic rhinitis may elucidate specific roles for TNF&#x003b1; in type-1 allergic inflammation, which may not be done in allergic asthma where type-1 features may be blurred by chronic inflammatory features.</p><p id="__p9" class="p p-last">The aim of the present study was to examine characteristics of the inflammatory process evoked by human nasal administration of TNF&#x003b1;. Nasal challenges with TNF&#x003b1; were carried out and the response was monitored by nasal lavages and biopsies and by analysis of granulocyte activation and plasma exudation markers as well as tissue numbers of granulocytes. Based on our previous study [<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400921">16</a>], we focused the evaluation on an observation point 24 hours post challenge. Healthy subjects and patients with allergic rhinitis (examined out of season) were included in order to get a preliminary estimation regarding whether or not these group of subjects differ with regard to TNF&#x003b1;-induced effects.</p></div><div id="__sec6" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec6title">Methods</h2><div id="__sec7" class="sec sec-first"><h3 id="__sec7title">Study Design</h3><p id="__p10" class="p p-first-last">The present study involved nasal administration of a single dose of TNF&#x003b1; (10 &#x003bc;g) in a single blind, sham-controlled (isotonic saline), randomized, and crossover design with a two-week washout period. Nasal lavages were carried out prior to and 24 hours post challenge. Furthermore, nasal mucosal biopsies were obtained 24 hours post-challenge. Lavage fluid levels of myeloperoxidase (MPO), eosinophil cationic protein (ECP), &#x003b1;<sub>2</sub>-macroglobulin, and IL-8 were measured as indices of neutrophil activity, eosinophil activity, plasma exudation, and pro-inflammatory cytokine production, respectively. Numbers of neutrophils and eosinophils in the biopsy material were determined. Nasal symptoms were scored at strategic time-points (below).</p></div><div id="__sec8" class="sec"><h3 id="__sec8title">Subjects</h3><p id="__p11" class="p p-first-last">Thirteen healthy subjects (5 females, 8 males, aged 20&#x02013;28 years) and 14 patients with seasonal allergic rhinitis (8 females, 6 males, aged 23&#x02013;45 years) participated in the study. The protocol was approved by the Regional Ethics Committee and written informed consent was obtained. The study was carried out in compliance with the Helsinki Declaration. For healthy subjects, inclusion criteria were: negative skin prick-test, normal nasal examination, and use of contraceptives (for females). Exclusion criteria were: history of respiratory tract infection within seven days of the start of the study, allergic and non-allergic rhinitis, other nasal disease (structural abnormalities, rhinosinusitis, and polyposis), use of decongestants within seven days of the start of the study, and use of other treatments (except occasional analgesics) within one month of the start of the study. For patients with allergic rhinitis, inclusion and exclusion criteria were the same as described above except that these subjects presented a history of at least two years of seasonal allergic rhinitis and a positive skin-prick test to relevant allergens (patients with positive tests for perennial allergens were excluded). Accordingly, eleven of the allergic subjects were skin-prick positive for both birch and timothy grass allergen, whereas one was sensitized to birch alone and one to timothy grass alone. None of the individuals had positive tests for house dust mite. Eight subjects had positive skin-prick tests for either cat or dog dander, but none of them were exposed to these animals on a regular basis.</p></div><div id="__sec9" class="sec"><h3 id="__sec9title">TNF&#x003b1; challenge</h3><p id="__p12" class="p p-first-last">Recombinant human TNF&#x003b1; (210-TA/CF, R&#x00026;D Systems, Abingdon, UK) was diluted with isotonic saline to a 100 &#x003bc;g/ml concentration. The solution was prepared less <span class="underline">than</span> one hour before the challenge and it was administered using a spray-device delivering 100 &#x003bc;l per actuation. The dose of 10 &#x003bc;g of TNF&#x003b1; was based on experience from our previous study [<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400953">16</a>]. Isotonic saline was used for the sham challenge. The challenges were given in a randomized order. The right hand side nasal cavity was challenged at the first visit and the left hand side at the second visit. The reason for using both nasal cavities was to avoid any influence of the first biopsy on the second challenge and sampling procedure. A washout period of two weeks was instituted between the challenges to make the repeated biopsy procedure more tolerable.</p></div><div id="__sec10" class="sec"><h3 id="__sec10title">Symptom scores</h3><p id="__p13" class="p p-first-last">Nasal symptoms were scored by the subjects prior to TNF&#x003b1; challenge and 24 hours thereafter. Sneezes, secretion, and blockage were each scored on a four-graded scale: 0 for no symptoms, 1 for mild symptoms, 2 for moderate symptoms, and 3 for severe symptoms. The scores were added to a total nasal symptom score (range 0&#x02013;9).</p></div><div id="__sec11" class="sec"><h3 id="__sec11title">Nasal lavages</h3><p id="__p14" class="p p-first-last">Nasal lavages with isotonic saline were carried out using a pool-device [<a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400927">18</a>]. The volume of the pool-fluid was 15 ml and it was kept in the nasal cavity for 5 min at each occasion. The lavages were performed immediately after the symptom scoring, before the challenge and before the nasal biopsy at 24 hours. The recovered fluid was centrifuged and the supernatant was homogenized, prepared in aliquots, and frozen (-30&#x000b0;C) for later analysis. The results were expressed as weight of analyte per volume without correction for any dilution of the lavage fluid: correction for dilution may be of little importance when high volume lavages are employed.</p></div><div id="__sec12" class="sec"><h3 id="__sec12title">Nasal biopsies</h3><p id="__p15" class="p p-first-last">The biopsy was obtained immediately after the second nasal lavage. Topical anaesthesia was applied using a solution of lidocaine hydrochloride (34.0 mg/ml) and nafazoline (0.17 mg/ml), delivered first by a spray-device and thereafter by a cotton swab. The biopsies were taken from the inferior aspect of the inferior turbinate about 0.5 cm from its anterior margin using a cutting-punch forceps with a drilled out punch (2 mm in diameter). Haemostasis was achieved using diathermy.</p></div><div id="__sec13" class="sec"><h3 id="__sec13title">Analysis</h3><p id="__p16" class="p p-first">&#x003b1;<sub>2</sub>-Macroglobulin was measured using a RIA sensitive to 7.8 ng/ml. Rabbit anti-human &#x003b1;<sub>2</sub>-macroglobulin (Dako, Copenhagen, Denmark) was used as anti-serum and human serum (Behringwerke, Marburg, Germany) as standard. Human &#x003b1;<sub>2</sub>-macroglobulin (Capell-Organon, Turnhout, Belgium) was iodinated. Tracer and standard or sample was mixed with antiserum before adding goat anti-rabbit anti-serum (AstraZeneca, Lund, Sweden). The bound fraction was measured using a gamma counter. The intra- and inter-assay coefficients of variation are between 3.8&#x02013;6.0% and 3.1&#x02013;7.2%, respectively. IL-8 was measured using a commercially available enzyme-linked immunosorbent assay (R&#x00026;D Systems, Abingdon, UK). ECP and MPO were also measured using commercially available assays (Phadia, Uppsala, Sweden and Calbiochem, Darmstadt, Germany, repectively). The limits of detection for IL-8, ECP and MPO were 31.2 pg/ml, 2.0 and 1.6 ng/ml, respectively.</p><p id="__p17" class="p p-last">The biopsies were immersed overnight in buffered 4% paraformaldehyde (pH 7.2), dehydrated in increasing concentrations of ethanol, embedded in paraffin, and sliced in 3 &#x003bc;m sections. After rinsing in TRIS-buffered saline, the sections were incubated with primary monoclonal antibodies overnight at 4&#x000b0;C. The monoclonal antibody EG2 (Phadia, dilution 1:200), which detects the eosinophil granule protein ECP, was used to identify eosinophils. Neutrophils were detected by a monoclonal antibody against the neutrophil granule protein MPO (Dako, A390, dilution 1:8000). After incubation with primary antibodies specimens were rinsed in TBS buffer and incubated with a secondary antibody (rabbit anti-mouse, Dako Z0109, dilution 1:80) for 40 min at room temperature. After washing in TBS the sections were incubated in mouse APAAP (Dako D0651, dilution 1:50 in 20% NHS) for 30 min, rinsed, and developed using New Fuchsin (Dako) as substrate. Endogenous alkaline phosphatase activity was inhibited by Levamisol (Dako). All sections were counter-stained with Harris\'s haematoxylin, coated with Aqua Perm mountant (484975 Life Sci. International), dried overnight, and mounted in Kaiser\'s glycerol gelatin (Merck, Darmstadt, Germany). The sections were blinded and the numbers of ECP-positive (eosinophils) and MPO-positive (neutrophils) subepithelial cells were counted down to a depth of 210 &#x003bc;m below the epithelial basement membrane. The numbers of eosinophils and neutrophils were expressed as cells/mm<sup>2 </sup>of tissue compartment.</p></div><div id="__sec14" class="sec sec-last"><h3 id="__sec14title">Statistics</h3><p id="__p18" class="p p-first-last">Differences in nasal lavage fluid levels of MPO, ECP, IL-8, and &#x003b1;<sub>2</sub>-macroglobulin as well as biopsy numbers of neutrophils and eosinophils, between observations following TNF&#x003b1; and sham challenge, were analyzed using the Wilcoxon signed rank test. A p-value less than 0.05 was considered significant. Data is presented as mean &#x000b1; S.E.M.</p></div></div><div id="__sec15" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec15title">Results</h2><p id="__p19" class="p p-first">One patient with allergic rhinitis was excluded from the study because of airway infection. Otherwise, all individuals complied with the protocol. Nasal administration of TNF&#x003b1; did not produce any nasal symptoms: score 0.8 &#x000b1; 0.3 post sham challenge and score 0.8 &#x000b1; 0.2 post TNF&#x003b1; (range 0&#x02013;9).</p><p id="__p20">Nasal lavage fluid levels of MPO recorded 24 hrs post TNF&#x003b1; challenge were increased in healthy subjects (p = 0.0081) and in patients with allergic rhinitis (p = 0.0081) (<em>c.f</em>. sham challenge) (Fig. <a href="/pmc/articles/PMC2253533/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1).</span></span><span>1</span></a>). Furthermore, &#x003b1;<sub>2</sub>-macroglobulin was increased in both these study groups (p = 0.014 and p = 0.0034, respectively) (Fig. <a href="/pmc/articles/PMC2253533/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2),</span></span><span>2</span></a>), indicating plasma exudation. ECP and IL-8 were not affected by TNF&#x003b1; challenge (Figs. <a href="/pmc/articles/PMC2253533/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Figs.3</span></span><span>3</span></a> and <a href="/pmc/articles/PMC2253533/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and4</span></span><span>4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2253533/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140446819696896" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2253533_1465-9921-9-15-1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1465-9921-9-15-1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2253533/bin/1465-9921-9-15-1.jpg" /></a></div><div id="largeobj_idm140446819696896" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2253533/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2253533/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p21">Nasal lavage fluid levels of MPO prior to and 24 hours post TNF&#x003b1; and sham challenge. (**p &#x0003c; 0.01).</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2253533/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140446747005600" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2253533_1465-9921-9-15-2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1465-9921-9-15-2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2253533/bin/1465-9921-9-15-2.jpg" /></a></div><div id="largeobj_idm140446747005600" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2253533/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2253533/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p22">Nasal lavage fluid levels of &#x003b1;<sub>2</sub>-macroglobulin prior to and 24 hours post TNF&#x003b1; and sham challenge. (*p &#x0003c; 0.05, **p &#x0003c; 0.01).</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC2253533/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140446747002912" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2253533_1465-9921-9-15-3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1465-9921-9-15-3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2253533/bin/1465-9921-9-15-3.jpg" /></a></div><div id="largeobj_idm140446747002912" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2253533/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC2253533/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p23">Nasal lavage fluid levels of ECP prior to and 24 hours post TNF&#x003b1; and sham challenge.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC2253533/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140446747000224" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2253533_1465-9921-9-15-4.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1465-9921-9-15-4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2253533/bin/1465-9921-9-15-4.jpg" /></a></div><div id="largeobj_idm140446747000224" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2253533/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC2253533/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p24">Nasal lavage fluid levels of IL-8 prior to and 24 hours post TNF&#x003b1; and sham challenge.</p></div></div></div><p id="__p25" class="p">TNF&#x003b1; increased the numbers of subepithelial neutrophils in the study material as a whole (p = 0.0021) (Fig. <a href="/pmc/articles/PMC2253533/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5):</span></span><span>5</span></a>): a subgroup analysis revealed that this change reflected a statistically significant increase in the healthy group (p = 0.0015), but not in the allergic rhinitis group (p = 0.204) (Fig. <a href="/pmc/articles/PMC2253533/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.6).</span></span><span>6</span></a>). Nasal biopsy numbers of eosinophils were unaffected by the TNF&#x003b1; challenge (Fig. <a href="/pmc/articles/PMC2253533/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.7).</span></span><span>7</span></a>). (Note, a non-significant difference 24 hours post sham challenge between healthy subjects and patients with allergic rhinitis also for eosinophils (p = 0.06, Mann Whitney).) Fig. <a href="/pmc/articles/PMC2253533/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2em;">Fig.8</span></span><span>8</span></a> shows micrographs of nasal mucosal neutrophils and eosinophils 24 hours post TNF&#x003b1; and sham challenge, respectively.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC2253533/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140446819635120" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2253533_1465-9921-9-15-5.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1465-9921-9-15-5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2253533/bin/1465-9921-9-15-5.jpg" /></a></div><div id="largeobj_idm140446819635120" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2253533/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC2253533/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p26">Numbers of subepithelial neutrophils in nasal biopsies obtained 24 hours post TNF&#x003b1; and sham challenge in the study material as a whole. (**p &#x0003c; 0.01).</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC2253533/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140446819632336" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2253533_1465-9921-9-15-6.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1465-9921-9-15-6.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2253533/bin/1465-9921-9-15-6.jpg" /></a></div><div id="largeobj_idm140446819632336" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2253533/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC2253533/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6</a></div><!--caption a7--><div class="caption"><p id="__p27">Numbers of subepithelial neutrophils in nasal biopsies obtained 24 hours post TNF&#x003b1; and sham challenge in healthy subjects and patients with allergic rhinitis. (**p &#x0003c; 0.01).</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F7" co-legend-rid="lgnd_F7"><a href="/pmc/articles/PMC2253533/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140446819629584" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2253533_1465-9921-9-15-7.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1465-9921-9-15-7.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2253533/bin/1465-9921-9-15-7.jpg" /></a></div><div id="largeobj_idm140446819629584" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2253533/figure/F7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F7"><div><a class="figpopup" href="/pmc/articles/PMC2253533/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7">Figure 7</a></div><!--caption a7--><div class="caption"><p id="__p28">Numbers of subepithelial eosinophils in nasal biopsies obtained 24 hours post TNF&#x003b1; and sham challenge in healthy subjects and patients with allergic rhinitis.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F8" co-legend-rid="lgnd_F8"><a href="/pmc/articles/PMC2253533/figure/F8/" target="figure" rid-figpopup="F8" rid-ob="ob-F8"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140446819626464" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2253533_1465-9921-9-15-8.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1465-9921-9-15-8.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2253533/bin/1465-9921-9-15-8.jpg" /></a></div><div id="largeobj_idm140446819626464" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2253533/figure/F8/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F8"><div><a class="figpopup" href="/pmc/articles/PMC2253533/figure/F8/" target="figure" rid-figpopup="F8" rid-ob="ob-F8">Figure 8</a></div><!--caption a7--><div class="caption"><p id="__p29">Micrographs showing nasal mucosal neutrophils and eosinophils 24 hours post TNF&#x003b1; and sham challenge. A: Sham-challenged healthy subject: biopsy stained for the neutrophil granule protein MPO. B: TNF&#x003b1; challenged patient with allergic rhinitis: biopsy stained for MPO. C: Sham-challenged healthy subject: biopsy stained for the eosinophil granule protein ECP. D: TNF&#x003b1; challenged healthy subject: biopsy stained for ECP. Nasal biopsy numbers of neutrophils were increased 24 hours after TNF&#x003b1; challenge.</p></div></div></div></div><div id="__sec16" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec16title">Discussion</h2><p id="__p30" class="p p-first">The present study, involving healthy subjects and patients with allergic rhinitis, demonstrates that intranasal TNF&#x003b1; produces a local inflammatory response. Our observation, together with our previous findings [<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400946">16</a>], suggests that this effect predominantly involves recruitment and activation of neutrophils and a low-grade exudative response 24 hours post challenge. The observation is of interest in terms of nasal airway defence/physiology and in terms of whether or not TNF&#x003b1; should be viewed as a pro-inflammatory factor in respiratory conditions characterised by inflammation.</p><p id="__p31">The dose of TNF&#x003b1; and the time-point for monitoring of the present response was chosen based on our previous observation: the 10 &#x003bc;g dose may be low, but has been shown to produce inflammatory effects 24 hours post challenge [<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400938">16</a>]. In the present study, the plasma exudation producing effect of TNF&#x003b1; (10 &#x003bc;g) at this time-point was confirmed. Taken together, our observations suggest that TNF&#x003b1; may not <em>per se </em>produce acute plasma exudation in human nasal airways (like, e.g., histamine would), but can induce an inflammatory condition that is characterised by "late-phase" plasma exudation. Plasma exudation is a specific feature of inflammation and increased levels of plasma proteins in airway mucosal surface liquids characterize allergic rhinitis and upper respiratory tract infections [<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400943">19</a>,<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400922">20</a>]. Accordingly, and supported by observations on increased levels of TNF&#x003b1; in allergic rhinitis [<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400934">13</a>,<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400926">14</a>] as well as common cold [<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400959">21</a>,<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400952">22</a>], TNF&#x003b1; may be a pro-inflammatory factor in inflammatory conditions of the nasal airway.</p><p id="__p32">Nasal lavage fluid levels of MPO were increased 24 hours post TNF&#x003b1; administration in healthy subjects and in patients with allergic rhinitis (this study). The finding is in agreement with our previous observation in allergic rhinitis, although that particular increase in MPO only reached borderline statistical significance [<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400948">16</a>]. Moreover, in the present study, nasal biopsy numbers of neutrophils, in the study group as a whole, were significantly increased post TNF&#x003b1; challenge further indicating a neutrophil-active effect of this cytokine. Our finding is in agreement with observations by Thomas <em>et al</em>. [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400936">9</a>,<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400939">10</a>], who reported sputum neutrophilia in healthy subjects as well as in patients with mild asthma following TNF&#x003b1; inhalation. Also in agreement, observations <em>in vitro </em>have identified TNF&#x003b1; as a factor that attracts [<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400942">23</a>] and, potentially, activates [<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400944">24</a>] neutrophil granulocytes. Taken together, available information now indicates that TNF&#x003b1; can be involved in neutrophil recruitment and activity in human airways. We have no specific explanation for the present numerically higher levels of MPO observed in healthy subjects (<em>c.f</em>. patients with allergic rhinitis) following TNF&#x003b1; challenge. However, this difference is not statistically significant (p = 0.5, Mann Whitney).</p><p id="__p33">In our previous study, involving patients with allergic rhinitis examined out of season, we observed moderately increased lavage fluid levels of ECP 24 hours after nasal TNF&#x003b1; challenge [<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400937">16</a>]. In contrast, in the present study, this observation could not be confirmed. We have no specific explanation for the discrepant findings, but a variable eosinophil activity at baseline may be one option: Thomas <em>et al</em>. observed that inhalation of TNF&#x003b1; to mild asthmatics increased eosinophil infiltration [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400949">9</a>] whereas this was not the case in healthy subjects [<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400954">10</a>]. In the present study, the biopsy analysis, which provides an additional aspect of cellular activity, showed that TNF&#x003b1; did not produce recruitment of eosinophils. Accordingly, our overall conclusion is that TNF&#x003b1; administered to patients with allergic rhinitis out of season, when there may be some degree of nasal eosinophilia but not at all as marked as during season allergen exposure, does not produce any marked pro-eosinophil effects. Further studies are warranted to examine effects of TNF&#x003b1; on eosinophil activities, tentatively involving patients with on-going allergic rhinitis.</p><p id="__p34">The present study was not powered to discriminate between healthy subjects and patients with allergic rhinitis, but may allow for a preliminary comparison. The only difference in TNF&#x003b1; induced effects between the groups was that the nasal mucosal numbers of neutrophils were increased in healthy subjects following TNF&#x003b1; challenge but not in patients with allergic rhinitis. However, TNF&#x003b1; did produce a numerical increase in neutrophils also in allergic rhinitis, which did not reach statistical significance (possibly due to a somewhat higher baseline). Furthermore, MPO, as marker of neutrophil activity, was significantly increased in both study groups. Taken together, no marked differences emerged between healthy subjects and patients with allergic rhinitis regarding TNF&#x003b1;-induced effects. However, further studies may be warranted in order to elucidate whether TNF&#x003b1; has a specific role in allergic airway conditions: such studies are warranted based on observations that patients with allergic rhinitis feature increased tissue expression of TNF&#x003b1; mRNA and TNF&#x003b1; protein [<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400941">13</a>-<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400958">15</a>]. Moreover, a basis for further exploration may be the recent observation that mice sensitized to ovalbumin and subjected to gene therapy (soluble TNF&#x003b1; receptor IgGFc fusion gene) present decreased symptoms and attenuated aggregation of mast cells, eosinophils, and IL-5 positive cells following nasal ovalbumin challenge [<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400957">25</a>]. Tentatively, further human <em>in vivo </em>studies may involve intervention with anti-TNF&#x003b1; measures in allergic rhinitis at seasonal allergen exposure.</p><p id="__p35" class="p p-last">Anti-TNF&#x003b1; drugs, including etanercept, have emerged as a possible treatment option for refractory asthma [<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400931">11</a>,<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145400920">12</a>]: reduction of symptoms, improvement in lung function, and reduction of bronchial hyperresponsiveness as a result of anti-TNF&#x003b1; intervention. A similar use of anti-TNF&#x003b1; drugs in allergic rhinitis is in our opinion not likely, in part reflecting that existing treatment options are very good and in part inherited difficulties with current anti-TNF&#x003b1; approaches. However, the human nasal airway and allergic rhinitis can be used to monitor effects of TNF&#x003b1; (this study) and anti-TNF&#x003b1; drugs. This may be particularly valid since there are key similarities between inflammatory processes of the upper and lower airways, since observations made in upper airway conditions frequently can be translated to the bronchial airway diseases, and since nasal airway studies are easier to perform. In this context, the present findings suggest, indirectly, that beneficial effects of anti-TNF&#x003b1; drugs in refractory asthma may reflect anti-neutrophil rather than anti-eosinophil effects.</p></div><div id="__sec17" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec17title">Conclusion</h2><p id="__p36" class="p p-first-last">Topical TNF&#x003b1; produces a nasal inflammatory response in humans that potentially is mediated through increased neutrophil activity.</p></div><div id="__sec18" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec18title">Competing interests</h2><p id="__p37" class="p p-first-last">The author(s) declare that they have no competing interests.</p></div><div id="__sec19" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec19title">Authors\' contributions</h2><p id="__p38" class="p p-first-last">All authors participated in the design process of the study. HW, MK, MA, and LG carried out the challenge, lavage/biopsy, and lavage analysis procedures. HW and JE performed the immunohistochemistry. HW and LG drafted the manuscript. All authors read and approved the final manuscript.</p></div><div id="idm140446786037488" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140446786037488title">Acknowledgements</h2><div class="sec"><div id="__sec20" class="sec sec-first"><h3 id="__sec20title"></h3><p id="__p39" class="p p-first-last">We thank Mrs. L. Glantz-Larsson, Mrs. C. Cervin-Hoberg, and Mrs. Gertrud Lundkvist for assistance. The study was supported in part by grants from the Swedish Research Council, Sk&#x000e5;ne County Council, and Lund University.</p></div></div></div><div id="idm140446786036000" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140446786036000title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="B1"><span class="citation">Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. <span><span class="ref-journal">N Engl J Med. </span>2004;<span class="ref-vol">350</span>(21):2167\xe2\x80\x932179. doi: 10.1056/NEJMra032906.</span> [<a href="/pubmed/15152062" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMra032906" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=New+drugs+for+rheumatoid+arthritis&amp;author=NJ+Olsen&amp;author=CM+Stein&amp;volume=350&amp;issue=21&amp;publication_year=2004&amp;pages=2167-2179&amp;pmid=15152062&amp;doi=10.1056/NEJMra032906&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B2"><span class="citation">Gosset P, Tsicopoulos A, Wallaert B, Joseph M, Capron A, Tonnel AB. Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. <span><span class="ref-journal">Am Rev Respir Dis. </span>1992;<span class="ref-vol">146</span>(3):768\xe2\x80\x93774.</span> [<a href="/pubmed/1519861" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+Rev+Respir+Dis&amp;title=Tumor+necrosis+factor+alpha+and+interleukin-6+production+by+human+mononuclear+phagocytes+from+allergic+asthmatics+after+IgE-dependent+stimulation&amp;author=P+Gosset&amp;author=A+Tsicopoulos&amp;author=B+Wallaert&amp;author=M+Joseph&amp;author=A+Capron&amp;volume=146&amp;issue=3&amp;publication_year=1992&amp;pages=768-774&amp;pmid=1519861&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B3"><span class="citation">Costa JJ, Matossian K, Resnick MB, Beil WJ, Wong DT, Gordon JR, Dvorak AM, Weller PF, Galli SJ. Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. <span><span class="ref-journal">J Clin Invest. </span>1993;<span class="ref-vol">91</span>(6):2673\xe2\x80\x932684.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC443331/">PMC free article</a>]</span> [<a href="/pubmed/8514874" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Human+eosinophils+can+express+the+cytokines+tumor+necrosis+factor-alpha+and+macrophage+inflammatory+protein-1+alpha&amp;author=JJ+Costa&amp;author=K+Matossian&amp;author=MB+Resnick&amp;author=WJ+Beil&amp;author=DT+Wong&amp;volume=91&amp;issue=6&amp;publication_year=1993&amp;pages=2673-2684&amp;pmid=8514874&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B4"><span class="citation">Finotto S, Ohno I, Marshall JS, Gauldie J, Denburg JA, Dolovich J, Clark DA, Jordana M. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis) <span><span class="ref-journal">J Immunol. </span>1994;<span class="ref-vol">153</span>(5):2278\xe2\x80\x932289.</span> [<a href="/pubmed/8051424" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=TNF-alpha+production+by+eosinophils+in+upper+airways+inflammation+(nasal+polyposis)&amp;author=S+Finotto&amp;author=I+Ohno&amp;author=JS+Marshall&amp;author=J+Gauldie&amp;author=JA+Denburg&amp;volume=153&amp;issue=5&amp;publication_year=1994&amp;pages=2278-2289&amp;pmid=8051424&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B5"><span class="citation">Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. <span><span class="ref-journal">Chest. </span>1994;<span class="ref-vol">105</span>(3):687\xe2\x80\x93696. doi: 10.1378/chest.105.3.687.</span> [<a href="/pubmed/8131526" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.105.3.687" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Detection+of+cytokines+and+their+cell+sources+in+bronchial+biopsy+specimens+from+asthmatic+patients.+Relationship+to+atopic+status,+symptoms,+and+level+of+airway+hyperresponsiveness&amp;author=V+Ackerman&amp;author=M+Marini&amp;author=E+Vittori&amp;author=A+Bellini&amp;author=G+Vassali&amp;volume=105&amp;issue=3&amp;publication_year=1994&amp;pages=687-696&amp;pmid=8131526&amp;doi=10.1378/chest.105.3.687&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B6"><span class="citation">Devalia JL, Campbell AM, Sapsford RJ, Rusznak C, Quint D, Godard P, Bousquet J, Davies RJ. Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. <span><span class="ref-journal">Am J Respir Cell Mol Biol. </span>1993;<span class="ref-vol">9</span>(3):271\xe2\x80\x93278.</span> [<a href="/pubmed/8398164" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Cell+Mol+Biol&amp;title=Effect+of+nitrogen+dioxide+on+synthesis+of+inflammatory+cytokines+expressed+by+human+bronchial+epithelial+cells+in+vitro&amp;author=JL+Devalia&amp;author=AM+Campbell&amp;author=RJ+Sapsford&amp;author=C+Rusznak&amp;author=D+Quint&amp;volume=9&amp;issue=3&amp;publication_year=1993&amp;pages=271-278&amp;pmid=8398164&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B7"><span class="citation">Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. <span><span class="ref-journal">Am J Respir Cell Mol Biol. </span>1994;<span class="ref-vol">10</span>(5):471\xe2\x80\x93480.</span> [<a href="/pubmed/8179909" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Cell+Mol+Biol&amp;title=Interleukin-4,+-5,+and+-6+and+tumor+necrosis+factor-alpha+in+normal+and+asthmatic+airways:+evidence+for+the+human+mast+cell+as+a+source+of+these+cytokines&amp;author=P+Bradding&amp;author=JA+Roberts&amp;author=KM+Britten&amp;author=S+Montefort&amp;author=R+Djukanovic&amp;volume=10&amp;issue=5&amp;publication_year=1994&amp;pages=471-480&amp;pmid=8179909&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B8"><span class="citation">Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. <span><span class="ref-journal">Nature. </span>1990;<span class="ref-vol">346</span>(6281):274\xe2\x80\x93276. doi: 10.1038/346274a0.</span> [<a href="/pubmed/2374592" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F346274a0" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Mast+cells+as+a+source+of+both+preformed+and+immunologically+inducible+TNF-alpha/cachectin&amp;author=JR+Gordon&amp;author=SJ+Galli&amp;volume=346&amp;issue=6281&amp;publication_year=1990&amp;pages=274-276&amp;pmid=2374592&amp;doi=10.1038/346274a0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B9"><span class="citation">Thomas PS, Heywood G. Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. <span><span class="ref-journal">Thorax. </span>2002;<span class="ref-vol">57</span>(9):774\xe2\x80\x93778. doi: 10.1136/thorax.57.9.774.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1746419/">PMC free article</a>]</span> [<a href="/pubmed/12200521" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fthorax.57.9.774" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thorax&amp;title=Effects+of+inhaled+tumour+necrosis+factor+alpha+in+subjects+with+mild+asthma&amp;author=PS+Thomas&amp;author=G+Heywood&amp;volume=57&amp;issue=9&amp;publication_year=2002&amp;pages=774-778&amp;pmid=12200521&amp;doi=10.1136/thorax.57.9.774&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B10"><span class="citation">Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>1995;<span class="ref-vol">152</span>(1):76\xe2\x80\x9380.</span> [<a href="/pubmed/7599866" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Tumor+necrosis+factor-alpha+increases+airway+responsiveness+and+sputum+neutrophilia+in+normal+human+subjects&amp;author=PS+Thomas&amp;author=DH+Yates&amp;author=PJ+Barnes&amp;volume=152&amp;issue=1&amp;publication_year=1995&amp;pages=76-80&amp;pmid=7599866&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B11"><span class="citation">Howarth PH, Babu KS, Arshad HS, Lau LC, Buckley MG, McConnell W, Beckett P, Ali MA, Chauhan A, Wilson SJ, et al.  Tumour Necrosis Factor (TNF{alpha}) as a novel therapeutic target in symptomatic corticosteroid-dependent asthma. <span><span class="ref-journal">Thorax. </span>2005</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1747263/">PMC free article</a>]</span> [<a href="/pubmed/16166100" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thorax&amp;title=Tumour+Necrosis+Factor+(TNF{alpha})+as+a+novel+therapeutic+target+in+symptomatic+corticosteroid-dependent+asthma&amp;author=PH+Howarth&amp;author=KS+Babu&amp;author=HS+Arshad&amp;author=LC+Lau&amp;author=MG+Buckley&amp;publication_year=2005&amp;pmid=16166100&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B12"><span class="citation">Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, Bradding P, Brightling CE, Wardlaw AJ, Pavord ID. Evidence of a role of tumor necrosis factor alpha in refractory asthma. <span><span class="ref-journal">N Engl J Med. </span>2006;<span class="ref-vol">354</span>(7):697\xe2\x80\x93708. doi: 10.1056/NEJMoa050580.</span> [<a href="/pubmed/16481637" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa050580" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Evidence+of+a+role+of+tumor+necrosis+factor+alpha+in+refractory+asthma&amp;author=MA+Berry&amp;author=B+Hargadon&amp;author=M+Shelley&amp;author=D+Parker&amp;author=DE+Shaw&amp;volume=354&amp;issue=7&amp;publication_year=2006&amp;pages=697-708&amp;pmid=16481637&amp;doi=10.1056/NEJMoa050580&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B13"><span class="citation">Bensch GW, Nelson HS, Borish LC. Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines. <span><span class="ref-journal">Ann Allergy Asthma Immunol. </span>2002;<span class="ref-vol">88</span>(5):457\xe2\x80\x93462.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1283081/">PMC free article</a>]</span> [<a href="/pubmed/12027065" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Allergy+Asthma+Immunol&amp;title=Evaluation+of+cytokines+in+nasal+secretions+after+nasal+antigen+challenge:+lack+of+influence+of+antihistamines&amp;author=GW+Bensch&amp;author=HS+Nelson&amp;author=LC+Borish&amp;volume=88&amp;issue=5&amp;publication_year=2002&amp;pages=457-462&amp;pmid=12027065&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B14"><span class="citation">Bradding P, Mediwake R, Feather IH, Madden J, Church MK, Holgate ST, Howarth PH. TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. <span><span class="ref-journal">Clin Exp Allergy. </span>1995;<span class="ref-vol">25</span>(5):406\xe2\x80\x93415. doi: 10.1111/j.1365-2222.1995.tb01071.x.</span> [<a href="/pubmed/7553243" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1365-2222.1995.tb01071.x" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Allergy&amp;title=TNF+alpha+is+localized+to+nasal+mucosal+mast+cells+and+is+released+in+acute+allergic+rhinitis&amp;author=P+Bradding&amp;author=R+Mediwake&amp;author=IH+Feather&amp;author=J+Madden&amp;author=MK+Church&amp;volume=25&amp;issue=5&amp;publication_year=1995&amp;pages=406-415&amp;pmid=7553243&amp;doi=10.1111/j.1365-2222.1995.tb01071.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B15"><span class="citation">Ying S, Robinson DS, Varney V, Meng Q, Tsicopoulos A, Moqbel R, Durham SR, Kay AB, Hamid Q. TNF alpha mRNA expression in allergic inflammation. <span><span class="ref-journal">Clin Exp Allergy. </span>1991;<span class="ref-vol">21</span>(6):745\xe2\x80\x93750. doi: 10.1111/j.1365-2222.1991.tb03205.x.</span> [<a href="/pubmed/1777835" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1365-2222.1991.tb03205.x" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Allergy&amp;title=TNF+alpha+mRNA+expression+in+allergic+inflammation&amp;author=S+Ying&amp;author=DS+Robinson&amp;author=V+Varney&amp;author=Q+Meng&amp;author=A+Tsicopoulos&amp;volume=21&amp;issue=6&amp;publication_year=1991&amp;pages=745-750&amp;pmid=1777835&amp;doi=10.1111/j.1365-2222.1991.tb03205.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B16"><span class="citation">Widegren H, Korsgren M, Andersson M, Greiff L. Effects of TNFalpha on the human nasal mucosa in vivo. <span><span class="ref-journal">Respir Med. </span>2007;<span class="ref-vol">101</span>(9):1982\xe2\x80\x931987. doi: 10.1016/j.rmed.2007.04.005.</span> [<a href="/pubmed/17532197" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.rmed.2007.04.005" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Respir+Med&amp;title=Effects+of+TNFalpha+on+the+human+nasal+mucosa+in+vivo&amp;author=H+Widegren&amp;author=M+Korsgren&amp;author=M+Andersson&amp;author=L+Greiff&amp;volume=101&amp;issue=9&amp;publication_year=2007&amp;pages=1982-1987&amp;pmid=17532197&amp;doi=10.1016/j.rmed.2007.04.005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B17"><span class="citation">Persson CG, Erjefalt JS, Greiff L, Andersson M, Erjefalt I, Godfrey RW, Korsgren M, Linden M, Sundler F, Svensson C. Plasma-derived proteins in airway defence, disease and repair of epithelial injury. <span><span class="ref-journal">Eur Respir J. </span>1998;<span class="ref-vol">11</span>(4):958\xe2\x80\x93970. doi: 10.1183/09031936.98.11040958.</span> [<a href="/pubmed/9623704" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1183%2F09031936.98.11040958" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&amp;title=Plasma-derived+proteins+in+airway+defence,+disease+and+repair+of+epithelial+injury&amp;author=CG+Persson&amp;author=JS+Erjefalt&amp;author=L+Greiff&amp;author=M+Andersson&amp;author=I+Erjefalt&amp;volume=11&amp;issue=4&amp;publication_year=1998&amp;pages=958-970&amp;pmid=9623704&amp;doi=10.1183/09031936.98.11040958&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B18"><span class="citation">Greiff L, Pipkorn U, Alkner U, Persson CG. The \'nasal pool\' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. <span><span class="ref-journal">Clin Exp Allergy. </span>1990;<span class="ref-vol">20</span>(3):253\xe2\x80\x93259. doi: 10.1111/j.1365-2222.1990.tb02680.x.</span> [<a href="/pubmed/2364306" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1365-2222.1990.tb02680.x" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Allergy&amp;title=The+\'nasal+pool\'+device+applies+controlled+concentrations+of+solutes+on+human+nasal+airway+mucosa+and+samples+its+surface+exudations/secretions&amp;author=L+Greiff&amp;author=U+Pipkorn&amp;author=U+Alkner&amp;author=CG+Persson&amp;volume=20&amp;issue=3&amp;publication_year=1990&amp;pages=253-259&amp;pmid=2364306&amp;doi=10.1111/j.1365-2222.1990.tb02680.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B19"><span class="citation">Svensson C, Andersson M, Persson CG, Venge P, Alkner U, Pipkorn U. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. <span><span class="ref-journal">J Allergy Clin Immunol. </span>1990;<span class="ref-vol">85</span>(5):828\xe2\x80\x93833. doi: 10.1016/0091-6749(90)90064-B.</span> [<a href="/pubmed/2332562" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0091-6749(90)90064-B" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol&amp;title=Albumin,+bradykinins,+and+eosinophil+cationic+protein+on+the+nasal+mucosal+surface+in+patients+with+hay+fever+during+natural+allergen+exposure&amp;author=C+Svensson&amp;author=M+Andersson&amp;author=CG+Persson&amp;author=P+Venge&amp;author=U+Alkner&amp;volume=85&amp;issue=5&amp;publication_year=1990&amp;pages=828-833&amp;pmid=2332562&amp;doi=10.1016/0091-6749(90)90064-B&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B20"><span class="citation">Akerlund A, Greiff L, Andersson M, Bende M, Alkner U, Persson CG. Mucosal exudation of fibrinogen in coronavirus-induced common colds. <span><span class="ref-journal">Acta Otolaryngol. </span>1993;<span class="ref-vol">113</span>(5):642\xe2\x80\x93648. doi: 10.3109/00016489309135878.</span> [<a href="/pubmed/8266793" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.3109%2F00016489309135878" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Otolaryngol&amp;title=Mucosal+exudation+of+fibrinogen+in+coronavirus-induced+common+colds&amp;author=A+Akerlund&amp;author=L+Greiff&amp;author=M+Andersson&amp;author=M+Bende&amp;author=U+Alkner&amp;volume=113&amp;issue=5&amp;publication_year=1993&amp;pages=642-648&amp;pmid=8266793&amp;doi=10.3109/00016489309135878&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B21"><span class="citation">Corne JM, Lau L, Scott SJ, Davies R, Johnston SL, Howarth PH. The relationship between atopic status and IL-10 nasal lavage levels in the acute and persistent inflammatory response to upper respiratory tract infection. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2001;<span class="ref-vol">163</span>(5):1101\xe2\x80\x931107.</span> [<a href="/pubmed/11316643" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=The+relationship+between+atopic+status+and+IL-10+nasal+lavage+levels+in+the+acute+and+persistent+inflammatory+response+to+upper+respiratory+tract+infection&amp;author=JM+Corne&amp;author=L+Lau&amp;author=SJ+Scott&amp;author=R+Davies&amp;author=SL+Johnston&amp;volume=163&amp;issue=5&amp;publication_year=2001&amp;pages=1101-1107&amp;pmid=11316643&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B22"><span class="citation">Klemens C, Rasp G, Jund F, Hilgert E, Devens C, Pfrogner E, Kramer MF. Mediators and cytokines in allergic and viral-triggered rhinitis. <span><span class="ref-journal">Allergy Asthma Proc. </span>2007;<span class="ref-vol">28</span>(4):434\xe2\x80\x93441. doi: 10.2500/aap.2007.28.3017.</span> [<a href="/pubmed/17883911" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2500%2Faap.2007.28.3017" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Allergy+Asthma+Proc&amp;title=Mediators+and+cytokines+in+allergic+and+viral-triggered+rhinitis&amp;author=C+Klemens&amp;author=G+Rasp&amp;author=F+Jund&amp;author=E+Hilgert&amp;author=C+Devens&amp;volume=28&amp;issue=4&amp;publication_year=2007&amp;pages=434-441&amp;pmid=17883911&amp;doi=10.2500/aap.2007.28.3017&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B23"><span class="citation">Kyan-Aung U, Haskard DO, Poston RN, Thornhill MH, Lee TH. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. <span><span class="ref-journal">J Immunol. </span>1991;<span class="ref-vol">146</span>(2):521\xe2\x80\x93528.</span> [<a href="/pubmed/1702804" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Endothelial+leukocyte+adhesion+molecule-1+and+intercellular+adhesion+molecule-1+mediate+the+adhesion+of+eosinophils+to+endothelial+cells+in+vitro+and+are+expressed+by+endothelium+in+allergic+cutaneous+inflammation+in+vivo&amp;author=U+Kyan-Aung&amp;author=DO+Haskard&amp;author=RN+Poston&amp;author=MH+Thornhill&amp;author=TH+Lee&amp;volume=146&amp;issue=2&amp;publication_year=1991&amp;pages=521-528&amp;pmid=1702804&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B24"><span class="citation">Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA., Jr Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. <span><span class="ref-journal">J Immunol. </span>1985;<span class="ref-vol">135</span>(3):2069\xe2\x80\x932073.</span> [<a href="/pubmed/3926894" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Activation+of+human+polymorphonuclear+neutrophil+functions+by+interferon-gamma+and+tumor+necrosis+factors&amp;author=MR+Shalaby&amp;author=BB+Aggarwal&amp;author=E+Rinderknecht&amp;author=LP+Svedersky&amp;author=BS+Finkle&amp;volume=135&amp;issue=3&amp;publication_year=1985&amp;pages=2069-2073&amp;pmid=3926894&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B25"><span class="citation">He J, Wang T, Yao L, Chen A, Zhou B, Yu H, Jia R, Cheng C, Huan L, Zhang Z. Construction and delivery of gene therapy vector containing soluble TNFalpha receptor-IgGFc fusion gene for the treatment of allergic rhinitis. <span><span class="ref-journal">Cytokine. </span>2006;<span class="ref-vol">36</span>(5&#x02013;6):296\xe2\x80\x93304. doi: 10.1016/j.cyto.2007.02.010.</span> [<a href="/pubmed/17379534" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.cyto.2007.02.010" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cytokine&amp;title=Construction+and+delivery+of+gene+therapy+vector+containing+soluble+TNFalpha+receptor-IgGFc+fusion+gene+for+the+treatment+of+allergic+rhinitis&amp;author=J+He&amp;author=T+Wang&amp;author=L+Yao&amp;author=A+Chen&amp;author=B+Zhou&amp;volume=36&amp;issue=5&#x02013;6&amp;publication_year=2006&amp;pages=296-304&amp;pmid=17379534&amp;doi=10.1016/j.cyto.2007.02.010&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2253533&amp;issue-id=161284&amp;journal-id=80&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Respiratory Research</span> are provided here courtesy of <strong>BioMed Central</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2253533/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2253533/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2253533/pdf/1465-9921-9-15.pdf">PDF (1.4M)</a></li> | <li><a href="#" data-citationid="PMC2253533" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2253533%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2253533%2F&amp;text=Effects%20of%20intranasal%20TNF%CE%B1%20on%20granulocyte%20recruitment%20and%20activity%20in%20healthy%20subjects%20and%20patients%20with%20allergic%20rhinitis"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2253533%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="18234086" data-aiid="2253533" data-aid="2253533" data-iid="161284" data-domainid="80" data-domain="rr" data-accid="PMC2253533" data-md5="b87353a13ba42d23a56191d7172c5e96"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:37:50-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BE427E99A08310000000009CD09CA&amp;ncbi_session=8A1BE427E99B12E1_2509SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2253533%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=rr&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2253533/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BE427E99B12E1_2509SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'